EMA-话题@MedSci

#EMA#

580篇内容 | 2459人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1317373, encodeId=40a1131e3733e, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：Sotatercept，活性受体融合蛋白，治疗骨髓增生异常综合征患者的贫血的疗效和安全性。, objectType=article, longId=126255, objectId=146e12625557, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=146e12625557, replyNumber=0, likeNumber=68, createdTime=2018-01-13, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=146e12625557, moduleTitle=Lancet haemat：Sotatercept，活性受体融合蛋白，治疗骨髓增生异常综合征患者的贫血的疗效和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=146e12625557)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317372, encodeId=81d8131e37233, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Diabetes Care：新型选择性PPARα调节剂Pemafibrate对2型糖尿病和高甘油三酯血症患者脂质代谢和糖代谢的影响！, objectType=article, longId=125507, objectId=a34212550e33, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a34212550e33, replyNumber=0, likeNumber=69, createdTime=2018-01-06, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a34212550e33, moduleTitle=Diabetes Care：新型选择性PPARα调节剂Pemafibrate对2型糖尿病和高甘油三酯血症患者脂质代谢和糖代谢的影响！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a34212550e33)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317371, encodeId=7211131e37152, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematology:缺铁女性如何补铁效果佳？不妨试试这些给药方案, objectType=article, longId=124771, objectId=d7fc124e716d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7fc124e716d, replyNumber=0, likeNumber=80, createdTime=2017-12-28, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7fc124e716d, moduleTitle=Lancet Haematology:缺铁女性如何补铁效果佳？不妨试试这些给药方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7fc124e716d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317370, encodeId=e941131e3708e, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：羟基脲治疗真红细胞增多症有证据了, objectType=article, longId=124754, objectId=d7e4124e549e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7e4124e549e, replyNumber=0, likeNumber=95, createdTime=2017-12-28, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7e4124e549e, moduleTitle=Am J Hematol：羟基脲治疗真红细胞增多症有证据了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7e4124e549e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317369, encodeId=04b3131e369c9, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：Momelotinib用于卢索替尼治疗失败的骨髓纤维化患者的效果。, objectType=article, longId=124148, objectId=bdea12414878, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdea12414878, replyNumber=0, likeNumber=59, createdTime=2017-12-23, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdea12414878, moduleTitle=Lancet haemat：Momelotinib用于卢索替尼治疗失败的骨髓纤维化患者的效果。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdea12414878)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317368, encodeId=2b18131e36829, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：利妥昔单抗用于化疗诱导缓解的慢性淋巴细胞白血病老年患者的维持治疗的效果和安全性。, objectType=article, longId=124145, objectId=d43c12414522, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d43c12414522, replyNumber=0, likeNumber=76, createdTime=2017-12-23, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d43c12414522, moduleTitle=Lancet haemat：利妥昔单抗用于化疗诱导缓解的慢性淋巴细胞白血病老年患者的维持治疗的效果和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d43c12414522)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317367, encodeId=633c131e3671f, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：恶性血液病患者进行干细胞移植后的亚临床影像。, objectType=article, longId=123493, objectId=bae612349398, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bae612349398, replyNumber=0, likeNumber=81, createdTime=2017-12-16, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bae612349398, moduleTitle=Lancet haemat：恶性血液病患者进行干细胞移植后的亚临床影像。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bae612349398)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317366, encodeId=5873131e36676, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haemat：弹力袜用于预防血栓形成后综合征，到底该穿多久？, objectType=article, longId=122611, objectId=d7491226114d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7491226114d, replyNumber=0, likeNumber=72, createdTime=2017-12-08, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7491226114d, moduleTitle=Lancet Haemat：弹力袜用于预防血栓形成后综合征，到底该穿多久？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7491226114d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317365, encodeId=11b4131e36584, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：ROAD能否作为复发侵袭性NHL患者的治疗选择？, objectType=article, longId=119139, objectId=605f11913951, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=605f11913951, replyNumber=0, likeNumber=58, createdTime=2017-11-09, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=605f11913951, moduleTitle=Am J Hematol：ROAD能否作为复发侵袭性NHL患者的治疗选择？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=605f11913951)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317364, encodeId=c318131e364cd, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：EPOCH联合利妥昔单抗治疗的淋巴瘤患者CNS复发率如何？, objectType=article, longId=119137, objectId=94bf11913e4a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94bf11913e4a, replyNumber=0, likeNumber=86, createdTime=2017-11-09, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94bf11913e4a, moduleTitle=Am J Hematol：EPOCH联合利妥昔单抗治疗的淋巴瘤患者CNS复发率如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94bf11913e4a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317363, encodeId=9537131e3634e, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematology：原发性中枢神经系统淋巴瘤患者高剂量氨甲喋呤化疗后的巩固方案——全脑放疗vs自体干细胞移植, objectType=article, longId=116692, objectId=5a5f11669245, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a5f11669245, replyNumber=0, likeNumber=15, createdTime=2017-10-20, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a5f11669245, moduleTitle=Lancet Haematology：原发性中枢神经系统淋巴瘤患者高剂量氨甲喋呤化疗后的巩固方案——全脑放疗vs自体干细胞移植, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a5f11669245)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317362, encodeId=c977131e36227, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematology：缺铁妇女补铁方案比较研究, objectType=article, longId=115637, objectId=567011563e21, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=567011563e21, replyNumber=0, likeNumber=137, createdTime=2017-10-12, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=567011563e21, moduleTitle=Lancet Haematology：缺铁妇女补铁方案比较研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=567011563e21)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317361, encodeId=9a06131e3611e, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：如何补铁吸收效果理想？, objectType=article, longId=115634, objectId=0adf1156347a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0adf1156347a, replyNumber=0, likeNumber=56, createdTime=2017-10-12, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0adf1156347a, moduleTitle=Lancet haemat：如何补铁吸收效果理想？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0adf1156347a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317360, encodeId=7923131e36002, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：输注储存35天以上的红细胞是否会影响患者院内死亡的风险？, objectType=article, longId=115462, objectId=80511154625f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80511154625f, replyNumber=0, likeNumber=83, createdTime=2017-10-11, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80511154625f, moduleTitle=Lancet haemat：输注储存35天以上的红细胞是否会影响患者院内死亡的风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80511154625f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317359, encodeId=24ad131e35955, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Int J Cancer：2005-2010年间FDA和EMA批准的抗癌药物的上市后研究, objectType=article, longId=114756, objectId=6f68114e565b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f68114e565b, replyNumber=0, likeNumber=53, createdTime=2017-09-30, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f68114e565b, moduleTitle=Int J Cancer：2005-2010年间FDA和EMA批准的抗癌药物的上市后研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f68114e565b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317358, encodeId=a3ac131e3584d, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：肝素诱导的血小板减少症患者存在哪些临床风险？, objectType=article, longId=114680, objectId=c5381146807a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5381146807a, replyNumber=0, likeNumber=71, createdTime=2017-09-30, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5381146807a, moduleTitle=Am J Hematol：肝素诱导的血小板减少症患者存在哪些临床风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5381146807a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317357, encodeId=6a14131e357f5, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：强化巩固治疗对老年急性髓性白血病患者有利, objectType=article, longId=114491, objectId=4611114491f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4611114491f7, replyNumber=0, likeNumber=113, createdTime=2017-09-29, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4611114491f7, moduleTitle=Am J Hematol：强化巩固治疗对老年急性髓性白血病患者有利, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4611114491f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317356, encodeId=3a44131e3565d, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：来那度胺用作慢性淋巴细胞白血病维持治疗的效果和安全性。, objectType=article, longId=114257, objectId=ba4711425e4c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba4711425e4c, replyNumber=0, likeNumber=71, createdTime=2017-09-28, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba4711425e4c, moduleTitle=Lancet haemat：来那度胺用作慢性淋巴细胞白血病维持治疗的效果和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba4711425e4c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317355, encodeId=948a131e3551f, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：全反式维甲酸联合达那唑治疗原发性免疫性血小板减少症的效果和安全性。, objectType=article, longId=112811, objectId=d4ff112811cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4ff112811cb, replyNumber=0, likeNumber=59, createdTime=2017-09-16, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4ff112811cb, moduleTitle=Lancet haemat：全反式维甲酸联合达那唑治疗原发性免疫性血小板减少症的效果和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4ff112811cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317354, encodeId=8a7a131e354cb, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：对于老年患者，自由性输血比限制性输血更能提高患者的存活率！, objectType=article, longId=112665, objectId=01ac112665f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01ac112665f3, replyNumber=0, likeNumber=103, createdTime=2017-09-14, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01ac112665f3, moduleTitle=Lancet haemat：对于老年患者，自由性输血比限制性输血更能提高患者的存活率！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01ac112665f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

EMA

2020-05-29

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：Sotatercept，活性受体融合蛋白，治疗骨髓增生异常综合征患者的贫血的疗效和安全性。

2018-01-13

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Diabetes Care：新型选择性PPARα调节剂Pemafibrate对2型糖尿病和高甘油三酯血症患者脂质代谢和糖代谢的影响！

2018-01-06

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematology:缺铁女性如何补铁效果佳？不妨试试这些给药方案

2017-12-28

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：羟基脲治疗真红细胞增多症有证据了

2017-12-28

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：Momelotinib用于卢索替尼治疗失败的骨髓纤维化患者的效果。

2017-12-23

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：利妥昔单抗用于化疗诱导缓解的慢性淋巴细胞白血病老年患者的维持治疗的效果和安全性。

2017-12-23

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：恶性血液病患者进行干细胞移植后的亚临床影像。

2017-12-16

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haemat：弹力袜用于预防血栓形成后综合征，到底该穿多久？

2017-12-08

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：ROAD能否作为复发侵袭性NHL患者的治疗选择？

2017-11-09

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：EPOCH联合利妥昔单抗治疗的淋巴瘤患者CNS复发率如何？

2017-11-09

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematology：原发性中枢神经系统淋巴瘤患者高剂量氨甲喋呤化疗后的巩固方案——全脑放疗vs自体干细胞移植

2017-10-20

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematology：缺铁妇女补铁方案比较研究

2017-10-12

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：如何补铁吸收效果理想？

2017-10-12

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：输注储存35天以上的红细胞是否会影响患者院内死亡的风险？

2017-10-11

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Int J Cancer：2005-2010年间FDA和EMA批准的抗癌药物的上市后研究

2017-09-30

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：肝素诱导的血小板减少症患者存在哪些临床风险？

2017-09-30

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：强化巩固治疗对老年急性髓性白血病患者有利

2017-09-29

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：来那度胺用作慢性淋巴细胞白血病维持治疗的效果和安全性。

2017-09-28

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：全反式维甲酸联合达那唑治疗原发性免疫性血小板减少症的效果和安全性。

2017-09-16

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：对于老年患者，自由性输血比限制性输血更能提高患者的存活率！

2017-09-14

科室
- - 订阅+
  - 更多科室
工具
服务